Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma: the randomized GMMG phase III trial ReLApsE von Goldschmidt, Hartmut, Baertsch, Marc-Andrea, Schlenzka, Jana, Becker, Natalia, Habermehl, Christina, Hielscher, Thomas, Raab, Marc-Steffen, Hillengass, Jens, Sauer, Sandra, Müller-Tidow, Carsten, Luntz, Steffen, Jauch, Anna, Hose, Dirk, Seckinger, Anja, Brossart, Peter, Goerner, Martin, Klein, Stefan, Schmidt-Hieber, Martin, Reimer, Peter, Graeven, Ullrich, Fenk, Roland, Haenel, Mathias, Martin, Hans, Lindemann, Hans W., Scheid, Christoph, Nogai, Axel, Salwender, Hans, Noppeney, Richard, Besemer, Britta, Weisel, Katja

Volltext

Reproducible Radiomics Features from Multi-MRI-Scanner Test-Retest-Study: Influence on Performance and Generalizability of Models von Wennmann, Markus, Rotkopf, Lukas T, Bauer, Fabian, Hielscher, Thomas, Kächele, Jessica, Mai, Elias K, Weinhold, Niels, Raab, Marc-Steffen, Goldschmidt, Hartmut, Weber, Tim F, Schlemmer, Heinz-Peter, Delorme, Stefan, Maier-Hein, Klaus, Neher, Peter

Volltext

A precision‐based exercise program for patients with multiple myeloma von Dapunt, Ulrike, Ehret, Pauline, Paratte, Jean‐Luc, Kuehl, Rea Maria, Wiskemann, Joachim, Jäger, Dirk, Müller‐Tidow, Carsten, Raab, Marc‐Steffen, Goldschmidt, Hartmut

Volltext

Cyclophosphamide etoposide dexamethasone as salvage and bridging therapy in relapsed refractory and extramedullary multiple myeloma von Kauer, Joseph, Sester, Lilli Sophie, Kriegsmann, Katharina, Weinhold, Niels, Ober, Michael, Müller‐Tidow, Carsten, Goldschmidt, Hartmut, Raab, Marc‐Steffen, Sauer, Sandra

Volltext

Whole‐body magnetic resonance imaging plus serological follow‐up for early identification of progression in smouldering myeloma patients to prevent development of end‐organ damage... von Wennmann, Markus, Goldschmidt, Hartmut, Mosebach, Jennifer, Hielscher, Thomas, Bäuerle, Tobias, Komljenovic, Dorde, McCarthy, Philip L., Merz, Maximilian, Schlemmer, Heinz‐Peter, Raab, Marc‐Steffen, Sauer, Sandra, Delorme, Stefan, Hillengass, Jens

Volltext

Pathway-Directed Therapy in Multiple Myeloma von John, Lukas, Krauth, Maria Theresa, Podar, Klaus, Raab, Marc-Steffen

Volltext

First‐line therapy with bendamustine/prednisone/bortezomib—A GMMG trial for non‐transplant eligible symptomatic multiple myeloma patients von Knauf, Wolfgang, Dingeldein, Gerrit, Schlag, Rudolf, Welslau, Manfred, Moehler, Thomas, Terzer, Tobias, Walter, Sarah, Habermehl, Christina, Kunz, Christina, Goldschmidt, Hartmut, Raab, Marc‐Steffen

Volltext

The prognostic significance of [18F]FDG PET/CT in multiple myeloma according to novel interpretation criteria (IMPeTUs) von Sachpekidis, Christos, Merz, Maximilian, Raab, Marc-Steffen, Bertsch, Uta, Weru, Vivienn, Kopp-Schneider, Annette, Jauch, Anna, Goldschmidt, Hartmut, Dimitrakopoulou-Strauss, Antonia

Volltext

Analysis of long‐term survival in multiple myeloma after first‐line autologous stem cell transplantation: impact of clinical risk factors and sustained response von Lehners, Nicola, Becker, Natalia, Benner, Axel, Pritsch, Maria, Löpprich, Martin, Mai, Elias Karl, Hillengass, Jens, Goldschmidt, Hartmut, Raab, Marc‐Steffen

Volltext

Extracellular vesicles mediate intercellular communication: Transfer of functionally active microRNAs by microvesicles into phagocytes von Claßen, Laura, Tykocinski, Lars‐Oliver, Wiedmann, Felix, Birr, Carolin, Schiller, Petra, Tucher, Christine, Krienke, Stefan, Raab, Marc‐Steffen, Blank, Norbert, Lorenz, Hanns‐Martin, Schiller, Martin

Volltext

Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma von Baertsch, Marc-Andrea, Fougereau, Mathilde, Hielscher, Thomas, Sauer, Sandra, Breitkreutz, Iris, Jordan, Karin, Müller-Tidow, Carsten, Goldschmidt, Hartmut, Raab, Marc-Steffen, Hillengass, Jens, Giesen, Nicola

Volltext

CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma-Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance von Seckinger, Anja, Hillengass, Jens, Emde, Martina, Beck, Susanne, Kimmich, Christoph, Dittrich, Tobias, Hundemer, Michael, Jauch, Anna, Hegenbart, Ute, Raab, Marc-Steffen, Ho, Anthony D, Schönland, Stefan, Hose, Dirk

Volltext

Inhibiting PI3K–AKT–mTOR Signaling in Multiple Myeloma-Associated Mesenchymal Stem Cells Impedes the Proliferation of Multiple Myeloma Cells von Heinemann, Luca, Möllers, Klara Maria, Ahmed, Helal Mohammed Mohammed, Wei, Lanying, Sun, Kaiyan, Nimmagadda, Subbaiah Chary, Frank, Daria, Baumann, Anja, Poos, Alexandra M., Dugas, Martin, Varghese, Julian, Raab, Marc-Steffen, Khandanpour, Cyrus

Volltext

IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells von Kehl, Niklas, Kilian, Michael, Michel, Julius, Wagner, Tim R, Uhrig, Sebastian, Brobeil, Alexander, Sester, Lilli-Sophie, Blobner, Sven, Steiger, Simon, Hundemer, Michael, Weinhold, Niels, Rippe, Karsten, Fröhling, Stefan, Eichmüller, Stefan B, Bunse, Lukas, Müller-Tidow, Carsten, Goldschmidt, Hartmut, Platten, Michael, Raab, Marc-Steffen, Friedrich, Mirco J

Volltext

Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results von Lesokhin, Alexander M., Tomasson, Michael H., Arnulf, Bertrand, Bahlis, Nizar J., Miles Prince, H., Niesvizky, Ruben, Rodrίguez-Otero, Paula, Martinez-Lopez, Joaquin, Koehne, Guenther, Touzeau, Cyrille, Jethava, Yogesh, Quach, Hang, Depaus, Julien, Yokoyama, Hisayuki, Gabayan, Afshin Eli, Stevens, Don A., Nooka, Ajay K., Manier, Salomon, Raje, Noopur, Iida, Shinsuke, Raab, Marc-Steffen, Searle, Emma, Leip, Eric, Sullivan, Sharon T., Conte, Umberto, Elmeliegy, Mohamed, Czibere, Akos, Viqueira, Andrea, Mohty, Mohamad

Volltext

Therapeutic Advances Propelled by Deciphering Tumor Biology and Immunology—Highlights of the 8th Heidelberg Myeloma Workshop von Lutz, Raphael, Friedrich, Mirco, Raab, Marc Steffen, Weinhold, Niels, Goldschmidt, Hartmut

Volltext

S188: CAR‐T CELLS SHAPE THE IMMUNOLOGICAL POTENTIAL OF THE TUMOR MICROENVIRONMENT von Frede, Julia, Poller, Julia, Shi, Kayleen, Stuart, Hannah, Sotoudeh, Noori, Lim, Klothilda, Wiggers, Caroline, Waldschmidt, Johannes, Dimitrova, Valeriya, Montanaro, Anna, Cho, Eugene, Vijaykumar, Tushara, Richardson, Paul, Munshi, Nikhil, Anderson, Kenneth, Martin, Nathan, Kaiser, Shari, Raab, Marc‐Steffen, Knoechel, Birgit, Lohr, Jens

Volltext

Expression of Mucin-1 in multiple myeloma and its precursors: correlation with glycosylation and subcellular localization von Andrulis, Mindaugas, Ellert, Elena, Mandel, Ulla, Clausen, Henrik, Lehners, Nicola, Raab, Marc-Steffen, Goldschmidt, Hartmut, Schwartz-Albiez, Reinhard

Volltext

The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients von Friedrich, Mirco J., Neri, Paola, Kehl, Niklas, Michel, Julius, Steiger, Simon, Kilian, Michael, Leblay, Noémie, Maity, Ranjan, Sankowski, Roman, Lee, Holly, Barakat, Elie, Ahn, Sungwoo, Weinhold, Niels, Rippe, Karsten, Bunse, Lukas, Platten, Michael, Goldschmidt, Hartmut, Müller-Tidow, Carsten, Raab, Marc-Steffen, Bahlis, Nizar J.

Volltext

Pharmacological Inhibition of Centrosome Clustering by Slingshot-Mediated Cofilin Activation and Actin Cortex Destabilization von Konotop, Gleb, Bausch, Elena, Nagai, Tomoaki, Turchinovich, Andrey, Becker, Natalia, Benner, Axel, Boutros, Michael, Mizuno, Kensaku, Krämer, Alwin, Raab, Marc Steffen

Volltext